Company · founded 2002
Intra Cellular Therapies (United States)
New York, United States · intracellulartherapies.com
- Citations, last 5 years
- 620
- Works, last 5 years
- 47
- h-index
- 93
- Scientists listed
- 3
- Grants since 2016
- 3
Grants received
2019–2022 · cooperative agreement · UG3
Development of ITI-333, a μ-opioid Receptor Partial Agonist and 5HT2A and D1 Receptor Antagonist, for the Treatment of Opioid Use Disorders
Sandra D Comer · Intra Cellular Therapies (United States) · funded by National Institutes of Health
2019–2025 · cooperative agreement · UG3
Development of ITI-333, a μ-opioid Receptor Partial Agonist and 5HT2A and D1 Receptor Antagonist, for the Treatment of Opioid Use Disorders
Sandra D Comer · Intra Cellular Therapies (United States) · funded by National Institutes of Health
2016–2018 · research · R43
Development of PDE2 Inhibitors for Treatment of Anxiety/Depression in Autism/Schizophrenia
Gretchen L Snyder · Intra Cellular Therapies (United States) · funded by National Institutes of Health